Tanya Wallace, Ph.

Affiliations: 
 
Google:
"Tanya Wallace"
Mean distance: 17.28 (cluster 29)
 

Parents

Sign in to add mentor
Charles V. Vorhees grad student 2000 University of Cincinnati
 (Behavioral and neurochemical consequences of methamphetamine -induced neurotoxicity.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Crane A, Brubaker WD, Johansson JU, et al. (2017) Peripheral complement interactions with amyloid β peptide in Alzheimer's disease: 2. Relationship to Aβ immunotherapy. Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Brubaker WD, Crane A, Johansson JU, et al. (2017) Peripheral complement interactions with amyloid β peptides in Alzheimer's disease: Erythrocyte clearance of amyloid β peptides. Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Wallace TL, Bertrand D. (2015) Neuronal α7 Nicotinic Receptors as a Target for the Treatment of Schizophrenia. International Review of Neurobiology. 124: 79-111
Goonawardena AV, Heiss J, Glavis-Bloom C, et al. (2015) Alterations in High-Frequency Neuronal Oscillations in a Cynomolgus Macaque Test of Sustained Attention Following NMDA Receptor Antagonism. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Wallace TL, Ballard TM, Glavis-Bloom C. (2015) Animal paradigms to assess cognition with translation to humans. Handbook of Experimental Pharmacology. 228: 27-57
Sahdeo S, Wallace T, Hirakawa R, et al. (2014) Characterization of RO5126946, a Novel α7 nicotinic acetylcholine receptor-positive allosteric modulator. The Journal of Pharmacology and Experimental Therapeutics. 350: 455-68
Umbricht D, Alberati D, Martin-Facklam M, et al. (2014) Effect of bitopertin, a glycine reuptake inhibitor, on negative symptoms of schizophrenia: a randomized, double-blind, proof-of-concept study. Jama Psychiatry. 71: 637-46
Wu YJ, He H, Gao Q, et al. (2014) Discovery of a cyclopentylamine as an orally active dual NK1 receptor antagonist-serotonin reuptake transporter inhibitor. Bioorganic & Medicinal Chemistry Letters. 24: 1611-4
Huang M, Felix AR, Kwon S, et al. (2014) The alpha-7 nicotinic receptor partial agonist/5-HT3 antagonist RG3487 enhances cortical and hippocampal dopamine and acetylcholine release. Psychopharmacology. 231: 2199-210
Wallace TL, Bertrand D. (2013) Importance of the nicotinic acetylcholine receptor system in the prefrontal cortex. Biochemical Pharmacology. 85: 1713-20
See more...